Overview

Amrize AG (NYSE: AMRZ), a building‑materials producer, released its third‑quarter 2026 financial results and full‑year guidance.

Financial Performance

  • Adjusted earnings per share were $1.05, surpassing the analyst consensus of $1.03.
  • Revenue reached $3.77 billion, a 2.2 % increase from $3.69 billion a year earlier, but missed the consensus estimate of $3.83 billion.
  • Net income rose 3.3 % to $558 million.
  • Adjusted EBITDA was $1.08 billion, up 0.2 % year‑on‑year.

Guidance

  • Full‑year 2026 revenue is now projected between $12.2 billion and $12.4 billion, with a midpoint of $12.3 billion, below the analyst consensus of $12.507 billion.
  • Adjusted EBITDA for 2026 is guided to a range of $2.95 billion to $3.05 billion.

Share Price Reaction

  • The market reacted negatively, with the share price falling 6.9 % following the announcement.

Operational Highlights

  • Margin expansion of 30 basis points was achieved in the Building Materials segment, driven by cement price increases of 1.8 % and aggregates price growth of 6.9 %.
  • Energy, fuel and freight surcharges contributed $23 million to earnings during the quarter.
  • The ASPIRE cost‑savings programme delivered $73 million of savings year‑to‑date and is on track to reach $80 million for the full year.

Capital Allocation

  • Capital expenditures totaled $262 million in the quarter.
  • The company returned $1.1 billion to shareholders through share buybacks and dividends in the first three quarters.
  • The $1 billion share‑repurchase programme was completed on 28 October 2026.
  • The Board declared a third‑quarter dividend of $0.11 per share, payable on 18 November 2026.

Acquisitions

  • Amrize completed the acquisition of Rapid Redi‑Mix, a ready‑mix concrete producer in the Dallas‑Fort Worth region, during the quarter.

Management Commentary

  • Chairman and CEO Jan Jenisch noted that oil‑price‑driven cost inflation continues to affect the industry, but the company is managing controllable factors through pricing, surcharges and the ASPIRE programme.